Citation |
Ballesteros C, Tritten L, O'Neill M, Burkman E, Zaky WI, Xia J, Moorhead A, Williams SA, Geary TG. The Effects of Ivermectin on Brugia malayi Females In Vitro: A Transcriptomic Approach.
PLoS Negl Trop Dis, 2016. |
Full Description
|
BACKGROUND: Lymphatic filariasis and onchocerciasis are disabling and disfiguring neglected tropical diseases of major importance in developing countries. Ivermectin is the drug of choice for mass drug administration programs for the control of onchocerciasis and lymphatic filariasis in areas where the diseases are co-endemic. Although ivermectin paralyzes somatic and pharyngeal muscles in many nematodes, these actions are poorly characterized in adult filariae. We hypothesize that paralysis of pharyngeal pumping by ivermectin in filariae could result in deprivation of essential nutrients, especially iron, inducing a wide range of responses evidenced by altered gene expression, changes in metabolic pathways, and altered developmental states in embryos. Previous studies have shown that ivermectin treatment significantly reduces microfilariae release from females within four days of exposure in vivo, while not markedly affecting adult worms. However, the mechanisms responsible for reduced production of microfilariae are poorly understood. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed transcriptomic profiles from Brugia malayi adult females, an important model for other filariae, using RNAseq technology after exposure in culture to ivermectin at various concentrations (100 nM, 300 nM and 1 M) and time points (24, 48, 72 h, and 5 days). Our analysis revealed drug-related changes in expression of genes involved in meiosis, as well as oxidative phosphorylation, which were significantly down-regulated as early as 24 h post-exposure. RNA interference phenotypes of the orthologs of these down-regulated genes in C. elegans include "maternal sterile", "embryonic lethal", "larval arrest", "larval lethal" and "sick". CONCLUSION/SIGNIFICANCE: These changes provide insight into the mechanisms involved in ivermectin-induced reduction in microfilaria output and impaired fertility, embryogenesis, and larval development. Experimental Details: RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447440 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447441 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447442 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447443 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447444 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447445 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447446 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447447 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447448 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447449 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447450 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447451 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447452 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066610.SRX1447453 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447454 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447455 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447456 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447457 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447458 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447459 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447460 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447461 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447462 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447463 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447464 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447465 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447466 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447467 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447468 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447469 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447470 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447471 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447472 RNASeq.brugia.WBStrain00041073.WBls:0000083.Female.WBbt:0007833.SRP066611.SRX1447473. |